News from all angles
(MedPage Today) -- Starting valbenazine (Ingrezza) to treat tardive dyskinesia might reduce antipsychotic discontinuation in patients newly diagnosed with the side effect, a retrospective cohort stud…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network